Search for Clinical Trial Results
Paresis - 146 Studies Found
Status | Study |
Completed |
Study Name: Transcutaneous Electroacupuncture for Gastroparesis Condition: Diabetic Gastroparesis Date: 2011-11-08 Interventions:
|
Active, not recruiting |
Study Name: A Pilot Study on the Efficacy and Safety of Olanzapine in Gastroparesis Condition: Idiopathic Gastroparesis Date: 2012-06-18 Interventions: Drug: Olanzapine Subjects will initially start on olanzapine 2.5 mg per mouth daily. Subjects will retur |
Terminated |
Study Name: Comparison of Two Macrolides, Azithromycin and Erythromycin, for Symptomatic Treatment of Gastroparesis Condition: Gastroparesis Date: 2011-03-24 Interventions:
|
Recruiting |
Study Name: Escalating Temporary Gastric Electrical Stimulation (GES) for Severe Gastroparesis Condition: Gastroparesis Date: 2014-06-06 |
Terminated |
Study Name: Diabetic Gastroparesis Efficacy/Safety Study of TZP-102 Condition: Diabetic Gastroparesis Date: 2012-08-10 Interventions:
|
Completed |
Study Name: MRI Brain Studies in Patients With HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis Condition: Tropical Spastic Paraparesis Date: 2002-05-01 |
Completed |
Study Name: Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) Condition: HTLV-I-Associated Myelopathy Date: 2011-04-25 Interventions: Drug: Tamibarotene Oral administration of tamibarotene 2 mg daily over a period of 12 weeks, then 4mg da |
Completed |
Study Name: Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) Condition: HTLV I Associated Myelopathy Date: 2008-10-15 Interventions: Drug: ciclosporin Ciclosporin 2.5 - 5mg/kg/day in two equally divided doses. dose adjusted according to |
Recruiting |
Study Name: Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Condition: HTLV-1 Date: 2006-07-12 Interventions: Drug: Hu MiK-Beta-1 |
Terminated |
Study Name: Safety and Efficiency Study of Valproic Acid In HAM/TSP Condition: HTLV-I-Associated Myelopathy Date: 2007-08-20 Interventions: Drug: Valproic Acid Valproic acid by oral route (20mg/Kg/day) during one year. |